摘要 |
The invention relates to N-oxides of tamoxifen analogs having activity for treating hyperproliferative disorders. Pharmaceutical compositions comprising therapeutically effective amount of an N-oxide of an estrogen receptor modulator, or a pharmaceutically acceptable salt or prodrug thereof, are disclosed. Further, the invention relates to methods of using the compounds, alone or in combination with one or more other active agents or treatments, to treat hyperproliferative disorders. |
申请人 |
NOVACEA, INC.;CURD, JOHN, G.;KEANA, JOHN, F.W.;LALANI, ALSHAD, S.;WESTBERG, PAUL, B. |
发明人 |
CURD, JOHN, G.;KEANA, JOHN, F.W.;LALANI, ALSHAD, S.;WESTBERG, PAUL, B. |